Article
Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System.
The Journal of molecular diagnostics : JMD - 1 Mar 2020
Lee Stacey, Taylor Jennifer L, Redmond Charles, Hadd Andrew G, Kemppainen Jon A, Haynes Brian C, Shone Scott, Bailey Donald B, Latham Gary J
Abstract excerpt
Newborn screening is designed for presymptomatic identification of serious conditions with effective early interventions. Clinical laboratories must perform prospective pilot studies to ensure that the analytical performance and workflow for a given screening test are appropriate. We assessed the potential to screen newborns for fragile X syndrome, a monogenic neurodevelopmental disorder, by establishing a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
